CD38 and primary cutaneous T-cell non-Hodgkin lymphoma: Recent studies by Ta et al. combined flow cytometry, single-cell sequencing, and immunohistochemistry to assess the expression of CD38 on neoplastic cells in blood and skin from patients with different CTCL subtypes.